A large pharmaceutical company conducting a Phase IV clinical investigation required a solution to quickly develop and deploy a series of eSource studies to test an investigational medication using a wearable patch for drug delivery. The sponsor worked with Clinical Ink and the eSource platform to develop a custom “parent” eSource study according to sponsor protocol for electronic deployment. Learn more about this company’s experience in a free case study.
What you’ll find in this case study:
- How Clinical Ink’s eSource solution expedited IRB approval and accelerated database lock
- How a custom study enabled real-time remote access to high-quality study data
- How Clinical Ink facilitated a highly adaptive clinical trial design for use and testing in sites